Posterior segment toxicity after gemcitabine and docetaxel chemotherapy

Ali Kord Valeshabad, William F. Mieler, Vikram Setlur, Merina Thomas, Mahnaz Shahidi

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Purpose. To report outer retinal disruption and uveal effusion after gemcitabine and docetaxel combination therapy. Case Report. A 78-year-old woman presented with blurry vision after two cycles of gemcitabine and docetaxel combination chemotherapy for stage IV sarcoma. At presentation, visual acuity was finger counting and 20/25 in the right and left eyes, respectively. Slit-lamp examination and B-scan ultrasonography revealed severe uveal effusion in the right eye and choroidal folds in the left eye. Spectral domain optical coherence tomography showed disruption of photoreceptor inner segment ellipsoid band in the right eye. The patient was monitored weekly with ophthalmic examination and B-scan ultrasonography, while continuing with gemcitabine monotherapy. At 8 weeks follow-up, uveal effusion improved considerably and visual acuity was 20/40 and 20/20 in the right and left eyes, respectively. Conclusions. Uveal effusion and outer retinal disruption were reported after gemcitabine and docetaxel chemotherapy. Early detection and close ophthalmic monitoring may allow concurrent cancer treatment and prevention of possible chemotherapy-induced ocular side effects.

Original languageEnglish (US)
Pages (from-to)e110-e113
JournalOptometry and Vision Science
Issue number5
StatePublished - May 6 2015
Externally publishedYes


  • chemotherapy
  • docetaxel
  • gemcitabine
  • retina
  • uveal effusion

ASJC Scopus subject areas

  • Ophthalmology
  • Optometry


Dive into the research topics of 'Posterior segment toxicity after gemcitabine and docetaxel chemotherapy'. Together they form a unique fingerprint.

Cite this